PacaƱa, Emmalou S.
HRN: 14-63-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/06/2022
ORAL
500mg
Q12
PROM, UTI
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes